clomipramine has been researched along with quetiapine fumarate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Matur, Z; Uçok, A | 1 |
| Etzensberger, M; Jaquenoud Sirot, E; Stephan, PL | 1 |
| Baumann, P; Eap, CB; Jaquenoud Sirot, E; Mueller, B; Stephan, PL | 1 |
| Cook, M; Rucker, J | 1 |
| Dainesi, SM; Diniz, JB; Hounie, AG; Koran, LM; Miguel, EC; Pereira, CA; Pimentel, I; Shavitt, RG | 1 |
| Diniz, JB; Fossaluza, V; Koran, L; Miguel, EC; Pereira, CA; Shavitt, RG | 1 |
| Cassab, RC; Costa, DL; Diniz, JB; Miguel, EC; Pereira, CA; Shavitt, RG | 1 |
| Ghezai, H; Goldacre, B; Hodsoll, J; Miles, S; Smallcombe, N; Veale, D | 1 |
| Fiedler, K; Gehrmann, A; Kittel-Schneider, S; Leutritz, AL; Preis, K; Scherf-Clavel, M; Unterecker, S; van Braam, L | 1 |
1 review(s) available for clomipramine and quetiapine fumarate
| Article | Year |
|---|---|
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clomipramine; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2014 |
3 trial(s) available for clomipramine and quetiapine fumarate
| Article | Year |
|---|---|
Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clomipramine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 2010 |
A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Clomipramine; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Follow-Up Studies; Humans; Middle Aged; Obsessive-Compulsive Disorder; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2011 |
The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Body Dysmorphic Disorders; Brazil; Clomipramine; Comorbidity; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Prospective Studies; Quetiapine Fumarate; Risk Factors; Treatment Outcome | 2014 |
5 other study(ies) available for clomipramine and quetiapine fumarate
| Article | Year |
|---|---|
Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Clomipramine; Dibenzothiazepines; Humans; Male; Obsessive-Compulsive Disorder; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Tourette Syndrome | 2003 |
[Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].
Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biological Availability; Clomipramine; Cytochrome P-450 CYP2D6; Delusions; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Genotype; Humans; Male; Mental Disorders; Metabolic Clearance Rate; Middle Aged; Pharmacogenetics; Psychotropic Drugs; Quetiapine Fumarate | 2006 |
Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cholelithiasis; Clomipramine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder, Major; Dibenzothiazepines; Humans; Liver; Male; Middle Aged; Phenotype; Quetiapine Fumarate | 2006 |
A case of prolonged seizure after ECT in a patient treated with clomipramine, lithium, L-tryptophan, quetiapine, and thyroxine for major depression.
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Clomipramine; Combined Modality Therapy; Depressive Disorder, Major; Dibenzothiazepines; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Lithium Compounds; Middle Aged; Quetiapine Fumarate; Recurrence; Status Epilepticus; Thyroxine; Tryptophan | 2008 |
Psychotropic medication in pregnancy and lactation and early development of exposed children.
Topics: Child; Clomipramine; Female; Humans; Infant, Newborn; Lactation; Pregnancy; Pregnancy Complications; Psychotropic Drugs; Quetiapine Fumarate; Sertraline | 2023 |